IDiyas

For the Inventor, By the Inventor

Hillsborough, NJ, United States of America

James H Simpson

USPTO Granted Patents = 12 

Average Co-Inventor Count = 7.8

ph-index = 3

Forward Citations = 24(Granted Patents)


Location History:

  • Belle Mead, NJ (US) (2000 - 2002)
  • Hillsborough, NJ (US) (2002 - 2016)

Company Filing History:

goldMedal12 out of 3,681 
 
Bristol-myers Squibb Compnay
 patents

Years Active: 2000-2016

where 'Filed Patents' based on already Granted Patents

12 patents (USPTO):
1. 9403821 - Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound (2016-08-02),
2. 9394322 - Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound (2016-07-19),
3. 9376458 - Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound (2016-06-28),
4. 9255113 - Methods for the Preparation of HIV attachment inhibitor piperazine prodrug compound (2016-02-09),
5. 9249168 - Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound (2016-02-02),
6. 9243010 - Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound (2016-01-26),
7. 8889869 - Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound (2014-11-18),
8. 7507838 - Process for the preparation of Z-5-carboxymethylene-1,3-dioxolan-4-ones (2009-03-24),
9. 6953679 - Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof (2005-10-11),
10. 6486315 - Recrystallization processes (2002-11-26),
11. 6340752 - Deprotection and recrystallization processes (2002-01-22),
12. 6162913 - Preparation of (2000-12-19),

Title: The Innovative Contributions of James H. Simpson

Introduction

James H. Simpson is a notable inventor based in Hillsborough, NJ (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 12 patents to his name, he has made remarkable strides in developing innovative solutions for medical challenges.

Latest Patents

Among his latest patents, James has focused on the "Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound." This method outlines a process for creating a compound that plays a crucial role in HIV treatment. His work in this area demonstrates his commitment to advancing medical science and improving patient outcomes.

Career Highlights

James H. Simpson is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role there allows him to leverage his expertise in drug development and contribute to groundbreaking research that addresses critical health issues.

Collaborations

Throughout his career, James has collaborated with esteemed colleagues, including Martin D. Eastgate and Michael S. Bultman. These partnerships have fostered a collaborative environment that enhances innovation and drives progress in their shared field.

Conclusion

James H. Simpson's work exemplifies the spirit of innovation in the pharmaceutical industry. His dedication to developing effective treatments for HIV and his collaborative efforts with fellow researchers highlight his significant impact on medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…